The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

Scoping review
by
Russell, Cayley et al

Release Date

2023

Geography

International

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

Yes

Peer Reviewed

Yes

Objective

A scoping review was undertaken to examine the impact of methamphetamine use on medications for opioid use disorder [MOUD] retention.

Findings/Key points

All eight included studies demonstrated an increased likelihood of treatment discontinuation or dropout among patients enrolled in MOUD who used methamphetamine. The frequency of methamphetamine use was also associated with MOUD dropout, in that those who used methamphetamine more often were more likely to discontinue MOUD. The definitions and measurements of MOUD retention varied considerably, as did the magnitude of effect size.

Design/methods

Scoping review (8 studies included)

Keywords

Stimulants
About PWUD
Substitution/OAT
Transitions in care/treatment